Search Results:
Material Type
- Blood (whole) (2)
- Buccal cells (1)
- Buffy coat (1)
- Cell lines (Derivative) (1)
- Dried whole blood (2)
- Isolated peripheral blood mononuclear cells (non viable) (1)
- Nasal washing (1)
- Other (1)
- Pathogen DNA (Derivative) (1)
- Plasma (double spun) (1)
- Plasma (single spun) (4)
- Red Blood Cells (1)
- Serum (6)
- Sputum (1)
- Stool (2)
- Swab medium (1)
- Urine (random) (2)
Microscopic Assessment
- Affected (2)
- Not applicable (7)
Storage Temperature
- RT (1)
- -35°C to -18°C (4)
- -85°C to -60°C (6)
- Liquid nitrogen (1)
Preservation Type
- N/A (1)
Associated Data
- Biomarker datasets (2)
- Clinical records (5)
- Followup records (5)
- Freezer temperature logs (5)
- Genomic datasets (1)
- Imaging data (2)
- Microbiological results (1)
- Participant Ethnicity (3)
- Physiological/biochemical measurements (2)
- Pre-analytical data (1)
- Primary care records (1)
- Quality indicators (2)
- Survey data (4)
- Treatment records (4)
Timeframe
- Immediate (3)
- 0 - 3 months (5)
- 3 - 6 months (2)
- > 6 months (2)
Biobank Services
Collection Type
- Case-control (2)
- Cohort (2)
- Cross-sectional (3)
- Disease specific (1)
Consent Restriction
Collection Status
- Completed (4)
- In progress (5)
- Not-started (3)
Access Condition
Country
- Belgium (1)
- Brazil (1)
- Peru (2)
- Philippines (1)
- Spain (1)
- Switzerland (1)
- Uganda (2)
- United States (1)
County
Onchocerciasis
101 - 500, Adolescent (12 - 18 years), Both sexes, Serum / Dried whole blood
101 - 500, Child (6 - 12 years), Both sexes, Serum / Dried whole blood
101 - 500, Young adult (18 - 40 years), Both sexes, Serum
Click for more details...
Peru TMRC One Health Approach to Fasciola
101 - 500, Adolescent (12 - 18 years), Both sexes, Plasma (single spun)
101 - 500, Adolescent (12 - 18 years), Both sexes, Serum
101 - 500, Adolescent (12 - 18 years), Both sexes, Stool
Click for more details...
Peru TMRC
101 - 500, Adolescent (12 - 18 years), Both sexes, Serum / Other / Urine (random) / Stool / Isolated peripheral blood mononuclear cells (non viable)
101 - 500, Adolescent (12 - 18 years), Both sexes, Stool / Urine (random) / Serum / Isolated peripheral blood mononuclear cells (non viable) / Other
101 - 500, Adult (> 40 years), Both sexes, Stool / Serum / Urine (random) / Isolated peripheral blood mononuclear cells (non viable)
Click for more details...
Test Biobank
101 - 500, Adolescent (12 - 18 years), Female, Buccal cells / Cell lines (Derivative) / Nasal washing / Plasma (single spun)
101 - 500, Adult (> 40 years), Female, Buccal cells / Cell lines (Derivative) / Nasal washing / Plasma (single spun)
101 - 500, Child (6 - 12 years), Female, Buccal cells / Cell lines (Derivative) / Nasal washing / Plasma (single spun)
Click for more details...
Uganda Schistosomiasis Multidisciplinary Research Centre
101 - 500, Young adult (18 - 40 years), Both sexes, Pathogen DNA (Derivative)
101 - 500, Young adult (18 - 40 years), Female, Pathogen DNA (Derivative)
101 - 500, Young child (2 - 6 years), Both sexes, Pathogen DNA (Derivative)
Click for more details...
Andalusian Public Health System Biobank
101 - 500, Adult (> 40 years), Both sexes, Blood (whole) / Buffy coat / Plasma (double spun) / Red Blood Cells / Serum
Click for more details...
Chagas Barriers Treatment
101 - 500, Young adult (18 - 40 years), Both sexes, Serum / Plasma (single spun) / Blood (whole)
Click for more details...
PRISM3 East Africa ICEMR
101 - 500, Adolescent (12 - 18 years), Female, Dried whole blood
101 - 500, Adult (> 40 years), Female, Dried whole blood
101 - 500, Adult (> 40 years), Male, Dried whole blood
Click for more details...
TMRC_Biomarkers_SjHepaticFibrosis
101 - 500, Young adult (18 - 40 years), Both sexes, Serum / Plasma (single spun)
Click for more details...